(Q39105277)

9 September 2017

title

miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells (English)

1 reference

9 September 2017

Yong Wang

1

1 reference

9 September 2017

Wei Zhao

series ordinal

2

1 reference

9 September 2017

Qin Fu

series ordinal

3

1 reference

9 September 2017

publication date

22 August 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

published in

1 reference

9 September 2017

volume

384

1 reference

9 September 2017

issue

1-2

1 reference

9 September 2017

page(s)

105-111

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1786-4

9 September 2017

exact match

0 references

cites work

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Biology and therapeutic advances for pediatric osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Role of microRNAs in drug-resistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Identification of hsa-miR-335 as a prognostic signature in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

MicroRNA-148a promotes myogenic differentiation by targeting the ROCK1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

miR-22 represses cancer progression by inducing cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

The ROCK signaling and breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

ROCK1 as a potential therapeutic target in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Placenta growth factor, PLGF, influences the motility of lung cancer cells, the role of Rho associated kinase, Rock1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Loss of mir-146a function in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Cancer metastasis: building a framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Cancer. The metastasis cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

MicroRNA Control of Invasion and Metastasis Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1786-4

Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor

21 January 2018

1 reference

12 December 2020

MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells

1 reference

12 December 2020

MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.

1 reference

12 December 2020

Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer

1 reference

12 December 2020

A preliminary report of neoadjuvant chemotherapy NSH-7 study in osteosarcoma: preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factor

1 reference

12 December 2020

10.1007/S11010-013-1786-4

Identifiers

DOI

1 reference

9 September 2017

1 reference